Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls

Clinica Chimica Acta

Volumn 421, Issue , 2013, Pages 140-146

  Meschiari, Cesar A ^a   Marcaccini, Andrea M ^a   Santos Moura, Bruna C ^a   Zuardi, Leonardo R ^a   Tanus Santos, Jose E ^a   Gerlach, Raquel F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Matrix metalloproteinases; Myeloperoxidase; Periodontal disease; Plasma; Saliva

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PERIODONTAL DISEASE; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVA LEVEL; ZYMOGRAPHY;

ADULT; CASE-CONTROL STUDIES; DENTAL SCALING; FEMALE; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PERIODONTITIS; PEROXIDASE; SALIVA; SALIVARY PROTEINS AND PEPTIDES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84876724827     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.03.008     Document Type: Article

References (49)

1. Gross J., Lapiere C.M. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 1962, 48:1014-1022.
2. Kwan J.A., Schulze C.J., Wang W., et al. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 2004, 18:690-692.
3. Birkedal-Hansen H., Moore W.G., Bodden M.K., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250.
4. Romanelli R., Mancini S., Laschinger C., Overall C.M., Sodek J., McCulloch C.A. Activation of neutrophil collagenase in periodontitis. Infect Immun 1999, 67:2319-2326.
5. Sorsa T., Tjaderhane L., Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004, 10:311-318.
6. Uitto V.J., Suomalainen K., Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res 1990, 25:135-142.
7. Westerlund U., Ingman T., Lukinmaa P.L., et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996, 75:1553-1563.
8. Gorska R., Nedzi-Gora M. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz) 2006, 54:419-426.
9. Marcaccini A.M., Novaes A.B., Meschiari C.A., et al. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clin Chim Acta 2009, 409:117-122.
10. Kaner D., Bernimoulin J.P., Kleber B.M., Heizmann W.R., Friedmann A. Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis. J Periodontal Res 2006, 41:132-139.
11. Marcaccini A.M., Meschiari C.A., Zuardi L.R., et al. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. J Clin Periodontol 2010, 37:180-190.
12. Wei P.F., Ho K.Y., Ho Y.P., Wu Y.M., Yang Y.H., Tsai C.C. The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1beta in gingival crevicular fluid: implications for oxidative stress in human periodontal diseases. J Periodontal Res 2004, 39:287-293.
13. Hernandez M., Gamonal J., Tervahartiala T., et al. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J Periodontol 2010, 81:1644-1652.
14. Floriano P.N., Christodoulides N., Miller C.S., et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem 2009, 55:1530-1538.
15. Saari H., Suomalainen K., Lindy O., Konttinen Y.T., Sorsa T. Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases. Biochem Biophys Res Commun 1990, 171:979-987.
16. Spallarossa P., Garibaldi S., Barisione C., et al. Postprandial serum induces apoptosis in endothelial cells: Role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity. Atherosclerosis 2008, 198:458-467.
17. Sakamoto W., Fujii Y., Kanehira T., Asano K., Izumi H. A novel assay system for myeloperoxidase activity in whole saliva. Clin Biochem 2008, 41:584-590.
18. Emekli-Alturfan E., Basar I., Malali E., et al. Plasma Tissue Factor Levels and Salivary Tissue Factor Activities of Periodontitis Patients with and without Cardiovascular Disease. Pathophysiol Haemost Thromb 2011, 37:77-81.
19. Marcaccini A.M., Meschiari C.A., Sorgi C.A., et al. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 2009, 80:594-602.
20. Blankenberg S., Rupprecht H.J., Poirier O., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003, 107:1579-1585.
21. Kuula H., Salo T., Pirila E., et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun 2009, 77:850-859.
22. Hernandez M., Gamonal J., Salo T., et al. Reduced expression of lipopolysaccharide-induced CXC chemokine in Porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice. J Periodontal Res 2011, 46:58-66.
23. Miller C.S., Foley J.D., Bailey A.L., et al. Current developments in salivary diagnostics. Biomark Med 2010, 4:171-189.
24. Loo J.A., Yan W., Ramachandran P., Wong D.T. Comparative human salivary and plasma proteomes. J Dent Res 2010, 89:1016-1023.
25. Lawrence H.P. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc 2002, 68:170-174.
26. Fine D.H., Markowitz K., Furgang D., et al. Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease?. J Periodontol 2009, 80:106-113.
27. Rigas B., Korenberg J.R., Merrill W.W., Levine L. Prostaglandins E2 and E2 alpha are elevated in saliva of cystic fibrosis patients. Am J Gastroenterol 1989, 84:1408-1412.
28. Tamashiro H., Constantine N.T. Serological diagnosis of HIV infection using oral fluid samples. Bull World Health Organ 1994, 72:135-143.
29. Greabu M., Purice M., Totan A., Spinu T., Totan C. Salivary cortisol-marker of stress response to different dental treatment. Rom J Intern Med 2006, 44:49-59.
30. Gursoy U.K., Kononen E., Huumonen S., et al. Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. J Clin Periodontol 2013, 40:18-25.
31. Oktay S., Basar I., Emekli-Alturfan E., et al. Serum and Saliva Sialic Acid in Periodontitis Patients with and without Cardiovascular Disease. Pathophysiol Haemost Thromb 2011, 37:67-71.
32. Gerlach R.F., Meschiari C.A., Marcaccini A.M., et al. Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions. Clin Chem Lab Med 2009, 47:888-891.
33. Gerlach R.F., Demacq C., Jung K., Tanus-Santos J.E. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clin Biochem 2007, 40:119-123.
34. Gerlach R.F., Uzuelli J.A., Souza-Tarla C.D., Tanus-Santos J.E. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal Biochem 2005, 344:147-149.
35. Souza-Tarla C.D., Uzuelli J.A., Machado A.A., Gerlach R.F., Tanus-Santos J.E. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Clin Biochem 2005, 38:410-414.
36. Buduneli E., Mantyla P., Emingil G., et al. Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level. J Periodontol 2011, 82:716-725.
37. Makela M., Salo T., Uitto V.J., Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994, 73:1397-1406.
38. Harrington D.J. Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease. Infect Immun 1996, 64:1885-1891.
39. Behle J.H., Sedaghatfar M.H., Demmer R.T., et al. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009, 36:287-294.
40. Thomadaki K., Bosch J.A., Oppenheim F.G., Helmerhorst E.J. The diagnostic potential of salivary protease activities in periodontal health and disease. Oral Dis 2013, http://dx.doi.org/10.1111/odi.12069.
41. Sorsa T., Ding Y., Salo T., et al. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci 1994, 732:112-131.
42. Isaza-Guzman D.M., Arias-Osorio C., Martinez-Pabon M.C., Tobon-Arroyave S.I. Salivary levels of matrix metalloproteinase (MMP)-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1: A pilot study about the relationship with periodontal status and MMP-9(-1562C/T) gene promoter polymorphism. Arch Oral Biol 2011, 56:401-411.
43. Kinney J.S., Morelli T., Braun T., et al. Saliva/Pathogen Biomarker Signatures and Periodontal Disease Progression. J Dent Res 2011, 90:752-758.
44. Gangbar S., Overall C.M., McCulloch C.A., Sodek J. Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodontal Res 1990, 25:257-267.
45. Miller C.S., King C.P., Langub M.C., Kryscio R.J., Thomas M.V. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006, 137:322-329.
46. Gursoy U.K., Kononen E., Pradhan-Palikhe P., et al. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010, 37:487-493.
47. Pietruska M., Pietruski J., Skurska A., et al. Assessment of aprotinin influence on periodontal clinical status and matrix metalloproteinases 1, 2 and their tissue inhibitors saliva concentrations in patients with chronic periodontitis. Adv Med Sci 2009, 54:239-246.
48. Narayanan A.S., Page R.C. Biochemical characterization of collagens synthesized by fibroblasts derived from normal and diseased human gingiva. J Biol Chem 1976, 251:5464-5471.
49. Furuholm J., Sorsa T., Qvarnstrom M., et al. Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease. J Periodontal Res 2006, 41:486-489.